press release – price-sensitive

  • TURNOVER AS OF 31 MARCH 2024 EQUAL TO 1.1 MILLION EUROS, AN INCREASE OF 26.3% COMPARED TO THE SAME PERIOD IN 2023

    TURNOVER AS OF 31 MARCH 2024 EQUAL TO 1.1 MILLION EUROS, AN INCREASE OF 26.3% COMPARED TO THE SAME PERIOD…
  • ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.

    ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF ARTERRA BIOSCIENCE S.P.A.
  • SECOND CALL OF SHAREHOLDERS’ MEETING

  • TURNOVER AS OF 31 DECEMBER 2023 EQUAL TO 3.3 MILLION EUROS

    TURNOVER AS OF 31 DECEMBER 2023 EQUAL TO 3.3 MILLION EUROS
  • CONCLUSION OF OWN SHARES BUY-BACK PROGRAM

    CONCLUSION OF OWN SHARES BUY-BACK PROGRAM
  • DIVIDEND DATE CORRECTION

    DIVIDEND DATE CORRECTION
  • THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022

    THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022
  • THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2021

    THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF DECEMBER 31, 2021
  • ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.

    ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF ARTERRA BIOSCIENCE S.P.A.
  • ARTERRA BIOSCIENCE WILL PARTICIPATE IN THE INVESTOR DAY ORGANIZED BY BANCA PROFILO ON APRIL 3 IN MILAN

    ARTERRA BIOSCIENCE WILL PARTICIPATE IN THE INVESTOR DAY ORGANIZED BY BANCA PROFILO ON APRIL 3 IN MILAN